Vertex Pharmaceuticals (VRTX) Cash from Restructuring (2009 - 2017)
Vertex Pharmaceuticals (VRTX) reported Cash from Restructuring of -$2.12 million for Q4 2017, compared with $725,000 a year earlier.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Cash from Restructuring (2009 - 2017) Analysis & Trends
For FY2017, Vertex Pharmaceuticals posted Cash from Restructuring of -$5.99 million.
- By year, Cash from Restructuring came in at -$7.43 million in FY2016, -$30.49 million in FY2015, $17.5 million in FY2014 (+248.3%) and $5.03 million in FY2013.
- Five-year quarterly Cash from Restructuring spans a low of -$24.37 million in Q1 2015 and a high of $36.62 million in Q3 2014.
- Per Business Quant data, the three quarters before Q4 2017 came in at -$2.81 million (Q3 2017), -$1.36 million (Q2 2017) and $305,000 (Q1 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2017 | -2.12 Mn |
| Sep 30, 2017 | -2.81 Mn |
| Jun 30, 2017 | -1.36 Mn |
| Mar 31, 2017 | 305,000.00 |
| Dec 31, 2016 | 725,000.00 |
| Sep 30, 2016 | -5.26 Mn |
| Jun 30, 2016 | -1.43 Mn |
| Mar 31, 2016 | -1.46 Mn |
| Dec 31, 2015 | -2.44 Mn |
| Sep 30, 2015 | -2.04 Mn |
| Jun 30, 2015 | -1.65 Mn |
| Mar 31, 2015 | -24.37 Mn |
| Dec 31, 2014 | -9.75 Mn |
| Sep 30, 2014 | 36.62 Mn |
| Jun 30, 2014 | -4.88 Mn |
| Mar 31, 2014 | -4.49 Mn |
| Dec 31, 2013 | 2.22 Mn |
| Sep 30, 2013 | 4.09 Mn |
| Jun 30, 2013 | -407,000.00 |
| Mar 31, 2013 | -869,000.00 |
API Access
Vertex Pharmaceuticals Cash from Restructuring API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-restructuring", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();